enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pharmaceuticals and Medical Devices Agency - Wikipedia

    en.wikipedia.org/wiki/Pharmaceuticals_and...

    It is similar in function to the Food and Drug Administration in the United States, the Medicines and Healthcare products Regulatory Agency in the United Kingdom, the Spanish Agency of Medicines and Medical Devices in Spain or the Food and Drug Administration in the Philippines. [2] The PhMDA has been eCTD compliant at least since December 2017 ...

  3. Sakigake (drug designation) - Wikipedia

    en.wikipedia.org/wiki/Sakigake_(drug_designation)

    Sakigake (さきがけ, lit. "pathfinder", "harbinger") is a drug designation by the Pharmaceuticals and Medical Devices Agency, the pharmaceuticals regulator of Japan. It was designed to provide easier access to novel advanced treatments. [1]

  4. List of stringent regulatory authorities - Wikipedia

    en.wikipedia.org/wiki/List_of_stringent...

    A stringent regulatory authority is a regulatory authority which is: a) a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), being the European Commission, the US Food and Drug Administration and the Ministry of Health, Labour and Welfare of Japan also represented by the Pharmaceuticals and Medical Devices Agency (as before ...

  5. Japanese Pharmacopoeia - Wikipedia

    en.wikipedia.org/wiki/Japanese_Pharmacopoeia

    The Japanese Pharmacopoeia ... Nihon Yakkyokuhō) is the official pharmacopoeia of Japan. It is published by the Pharmaceuticals and Medical Devices Agency ...

  6. The drug was approved in the U.S. and Japan last year, and it is under review in Europe. Eisai is aiming to introduce Leqembi in China this year following approval by regulators there in January.

  7. Act on Securing Quality, Efficacy and Safety of Products ...

    en.wikipedia.org/wiki/Act_on_Securing_Quality...

    This article needs to be updated.The reason given is: there was a significant revision to Japan's Pharmaceuticals and Medical Devices Act (PMD Act) in December 4, 2019 (令和 元 年12月 4日) and certain articles in this revised PMD Act took effect April 1, 2020, September 1, 2020, and August 1, 2021; other articles will take effect Dec. 1, 2022 (see also: https://www.natlawreview.com ...

  8. ELIQUIS® (apixaban) Approved In Japan For The ... - AOL

    www.aol.com/news/2012-12-26-eliquis-apixaban...

    ELIQUIS ® (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)-- Bristol ...

  9. No, Japan didn’t name COVID-19 vaccine ‘most deadly drug in ...

    www.aol.com/news/no-japan-didn-t-name-145124745.html

    The claim: Japan declared COVID-19 vaccine is ‘the most deadly drug in history’ A Nov. 8 Facebook post (direct link, archive link) claims another country issued a dire warning about the COVID ...